LEADER 03284nam 2200613Ia 450 001 9910782042703321 005 20230617010156.0 010 $a0-309-16514-8 010 $a1-280-74214-3 010 $a9786610742141 010 $a0-309-54931-0 035 $a(CKB)1000000000521982 035 $a(EBL)3564107 035 $a(SSID)ssj0000277065 035 $a(PQKBManifestationID)11231511 035 $a(PQKBTitleCode)TC0000277065 035 $a(PQKBWorkID)10233678 035 $a(PQKB)11515265 035 $a(MiAaPQ)EBC3564107 035 $a(Au-PeEL)EBL3564107 035 $a(CaPaEBR)ebr10160727 035 $a(CaONFJC)MIL74214 035 $a(OCoLC)61505165 035 $a(EXLCZ)991000000000521982 100 $a20050620d2005 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAssessment of the scientific information for the Radiation Exposure Screening and Education Program$b[electronic resource] /$fCommittee to Assess the Scientific Information for the Radiation Exposure Screening and Education Program, Board on Radiation Effects Research, Division on Earth and Life Studies 210 $aWashington, D.C. $cNational Academies Press$d2005 215 $a1 online resource (429 p.) 300 $aDescription based upon print version of record. 311 $a0-309-09610-3 320 $aIncludes bibliographical references. 327 $a""Front Matter""; ""Acknowledgments""; ""Reviewers""; ""A Note on the Units of Measurement Used in this Report""; ""Contents""; ""Executive Summary""; ""1 Introduction""; ""2 Legislation and Compensation""; ""3 Basic Concepts in Radiation Physics, Biology, and Epidemiology""; ""4 Review of Recent Data on Radiation Epidemiology, Biology, and Dosimetry""; ""5 Expanding RECA Eligibility: Scientific Issues""; ""6 Expanding RECA Eligibility: Implementation""; ""7 Diseases, Populations, and Other Issues of Public Concern""; ""8 Ethical Framework""; ""9 Medical Screening"" 327 $a""10 Screening for Compensation""""11 Education and Outreach""; ""References""; ""Appendixes""; ""Appendix A Invited Speakers and Public Comment""; ""Appendix B A Comparison of the Risk of Skin Cancer with the Risk of Lung Cancer from Exposure to Radon Decay Products in Underground Mines""; ""Appendix C Radioactivity in Guam After Nuclear- Weapons Testing in the Pacific""; ""Appendix D The Optimal Criterion for Positivity in Screening""; ""Appendix E Selected Cancer-Screening Recommendations""; ""Glossary""; ""List of Abbreviations""; ""Committee and Staff Biographies"" 606 $aNuclear weapons$zUnited States$xTesting 606 $aRadiation dosimetry 606 $aRadiation$xPhysiological effect$xResearch$zUnited States 606 $aRadiation$xSafety measures 615 0$aNuclear weapons$xTesting. 615 0$aRadiation dosimetry. 615 0$aRadiation$xPhysiological effect$xResearch 615 0$aRadiation$xSafety measures. 676 $a363.1799 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910782042703321 996 $aAssessment of the scientific information for the Radiation Exposure Screening and Education Program$93802362 997 $aUNINA LEADER 03375nam 2200409 450 001 9910816075803321 005 20230627180332.0 010 $a1-58528-543-9 035 $a(MiAaPQ)EBC30448648 035 $a(Au-PeEL)EBL30448648 035 $a(OCoLC)1081297785 035 $a(EXLCZ)9926291021000041 100 $a20230627h20172018 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aLearning and mastering pharmaceutical calculations /$fNicholas Ferencz 205 $aFirst edition. 210 1$aBethesda, MD :$cAmerican Society of Health-System Pharmacists, Inc.,$d[2017] 210 4$dİ2018 215 $a1 online resource (188 pages) 311 08$aPrint version: Ferencz, Nicholas Learning and Mastering Pharmaceutical Calculations Bethesda : American Society of Health-System Pharmacists,c2018 327 $aFerenczPharmaCalc_00_FM -- FerenczPharmaCalc_01_Ch01 -- FerenczPharmaCalc_02_Ch02 -- FerenczPharmaCalc_03_Ch03 -- FerenczPharmaCalc_04_ProgressTest -- FerenczPharmaCalc_05_Ch04 -- FerenczPharmaCalc_06_Ch05 -- FerenczPharmaCalc_07_Ch06 -- FerenczPharmaCalc_08_Ch07 -- FerenczPharmaCalc_09_Ch08 -- FerenczPharmaCalc_10_Ch09 -- FerenczPharmaCalc_11_Ch10 -- FerenczPharmaCalc_12_Ch11 -- FerenczPharmaCalc_13_Ch12 -- FerenczPharmaCalc_14_Ans_Ch01 -- FerenczPharmaCalc_15_Ans_Ch02 -- FerenczPharmaCalc_16_Ans_Ch03 -- FerenczPharmaCalc_17_Ans_ProgressTest -- FerenczPharmaCalc_18_Ans_Ch04 -- FerenczPharmaCalc_19_Ans_Ch05 -- FerenczPharmaCalc_20_Ans_Ch06 -- FerenczPharmaCalc_21_Ans_Ch07 -- FerenczPharmaCalc_22_Ans_Ch08 -- FerenczPharmaCalc_23_Ans_Ch09 -- FerenczPharmaCalc_24_Ans_Ch10 -- FerenczPharmaCalc_25_Ans_Ch11 -- FerenczPharmaCalc_26_Ans_Ch12 -- FerenczPharmaCalc_27_Glossary. 330 $aA valuable supplement to any pharmacy math course or textbook, Learning and Mastering Pharmaceutical Calculations makes the process of sharpening critical calculation skills more efficient and effective for students and technicians at all levels of experience, as well as practitioners looking to refresh their skills. Written by Nicholas Ferencz, Pharm.D., Ph.D., this unique new workbook enhances the learning experience in several ways. Learners can assess their skills and choose the progressive learning paths that fit their needs, starting with the chapters that match their abilities. * Two pathways to learning: one covers basic concepts and skills for calculations and compounding; the other is advanced, with a progress test to measure aptitude. * Focus is on how to go about solving mathematical problems. * Problems presented in step-by-step phases, breaking complicated calculations into manageable stages for easier analysis. * Easy-to-follow outline format with statement of goals, key terms, worked problems, and solutions. * Additional review problems and solutions in the appendix. * Calculations problems tied to all areas and aspects of pharmaceutical practice. 606 $aPharmaceutical arithmetic 615 0$aPharmaceutical arithmetic. 676 $a615.1/401513 700 $aFerencz$b Nicholas$01720332 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910816075803321 996 $aLearning and mastering pharmaceutical calculations$94118897 997 $aUNINA